Loading...
*  Vaccine-preventable diseases
The WHO lists 25 diseases for which vaccines are available: Measles Rubella Cholera Meningococcal disease Influenza Diphtheria ... Vaccine-preventable deaths are usually caused by a failure to obtain the vaccine in a timely manner. This may be due to ... If a vaccine-preventable disease is uncommon in a country, then residents of that country are unlikely to receive a vaccine ... A vaccine-preventable disease is an infectious disease for which an effective preventive vaccine exists. If a person acquires a ...
*  Meningococcal vaccine
... refers to any of the vaccines used to prevent infection by Neisseria meningitidis. Different versions are ... 2000). "Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults". Vaccine. ... This is the first meningococcal vaccine that can be given to infants as young as six weeks old. A vaccine called MenAfriVac has ... "Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine". Clin ...
*  MenAfriVac
12 September 2013). "Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis ... "The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group A Meningococcal Conjugate ... 61, Issue suppl_5. "MenAfriVac Meningococcal A Conjugate Vaccine". seruminstitute.com. Serum Institute of India. 2011. ... World Health Organization (February 2015). "Meningococcal A conjugate vaccine: updated guidance. World Health Organization" ( ...
*  Neisseria meningitidis
A meningococcal polysaccharide vaccine (MPSV4) has been available since the 1970s and is the only meningococcal vaccine ... A number of vaccines are available in the U.S. to prevent meningococcal disease. Some of the vaccines cover serogroup B, while ... Two meningococcal conjugate vaccines (MCV4) are licensed for use in the U.S. The first conjugate vaccine was licensed in 2005, ... "First vaccine approved by FDA to prevent serogroup B Meningococcal disease" (Press release). FDA. 29 October 2014. Kate Kelland ...
*  Meningitis
"A new MenB (meningococcal B) vaccine". Meningitis Research Foundation. Archived from the original on 29 November 2014. ... A quadrivalent vaccine now exists, which combines four vaccines with the exception of B; immunization with this ACW135Y vaccine ... Meningococcus vaccines exist against groups A, B, C, W135 and Y. In countries where the vaccine for meningococcus group C was ... FDA News Release (29 October 2014). "First vaccine approved by FDA to prevent serogroup B Meningococcal disease". FDA. Archived ...
*  Claire V. Broome
Group B meningococcal vaccine efficacy in Cuba; and Haemophilus influenza type b conjugate vaccine impact on pneumonia in the ... pneumococcal vaccine evaluation, meningococcal disease and Toxic Shock Syndrome. Notable accomplishments included development ... design of field trials to evaluate vaccine performance, including duration of meningococcal effectiveness in Burkina Faso; ... Consultative Group on Vaccine development, Children's Vaccine Initiative Project). As an EIS officer at the CDC within the ...
*  Meningococcal disease
Although conjugate vaccines are the preferred meningococcal vaccine in adolescents 11 years of age or older, polysaccharide ... Although conjugate vaccines are the preferred meningococcal vaccine in adults 55 years of age or younger, polysaccharide ... During epidemics the incidence of meningococcal disease approaches 100 per 100,000. Meningococcal vaccines have sharply reduced ... Vaccines are currently available against all six strains, including the newest vaccine against serogroup B. The first vaccine ...
*  Dlawer Ala'Aldeen
He also holds patents for anti-Campylobacter agents and meningococcal vaccine candidates. He was chairman or member of a number ... Screening of neisserial vaccine candidates and vaccines against pathogenic ... - Google Patents Journal of Medical Microbiology ... From 1988 to 2014, Ala'Aldeen has worked on pathogenesis, molecular epidemiology and vaccine development of various bacterial ... Molecular and Clinical Aspects of Bacterial Vaccine Development; and Medical Microbiology. ...
*  Australian Vaccination-Skeptics Network
The AVN campaigned against the introduction of a meningococcal vaccine to Australia in 2002. Meryl Dorey accused the government ... "Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005 - Meningococcal". Communicable Diseases ... "The vaccine manufacturers know they've got to through this process and pass all the tests to demonstrate that the vaccine is ... Tunkel, Allan (2001). "Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England". Current ...
*  Natasha Anwar
"Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants". The ... Vaccines exist for serogroups A, C, W135, and Y. No effective vaccine exists for the variations of serogroup B. As a result, ... Meningococcal Research Group (1999). "Assessment of immune response to meningococcal disease: Comparison of a whole-blood assay ... It is usually commensal, but will sometimes become pathogenic, attacking the host and causing meningococcal disease. If the ...
*  Conjugate vaccine
B cell Haemophilus influenzae type b (Hib) Hib vaccine Immunogenicity Meningococcal vaccine Pneumococcal vaccines Rappuoli, ... Vaccines, Conjugate at the US National Library of Medicine Medical Subject Headings (MeSH) "Conjugate Vaccines Against Enteric ... "Use of carrier protein for development of protein/polysaccharide conjugate vaccines and protein/protein conjugate vaccines". ... A conjugate vaccine is created by covalently attaching a poor antigen to a strong antigen thereby eliciting a stronger ...
*  George Siber bibliography
"Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized ... "Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults". Vaccine. 25 (33): 6164-6. doi:10.1016/j.vaccine ... Vaccine-type and non-vaccine type pneumococci after administration of 9valent CRM 197 conjugate pneumococcal vaccine (Pnc CRM9 ... 2008). Pneumococcal vaccines : the impact of conjugate vaccine. Washington, DC: ASM Press. ISBN 9781555814083. Eshelman, Fred N ...
*  NmVac4-A/C/Y/W-135
... meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old ... NmVac4-A/C/Y/W-135 is the commercial name of the Meningococcal meningitis polysaccharide serogroups A,C,Y and W-135 vaccine of ... Meningococcal meningitis vaccine containing serogroups A, C, Y, W-135 is currently required by Saudi Arabia for pilgrims ... Meningococcal polysaccharide vaccines are efficacious to protect from meningitis disease in adults, but cannot provide full ...
*  Gonorrhea
A study published in 2017 showed that MeNZB group B meningococcal vaccine provided a partial protection against gonorrhea. The ... Petousis-Harris, Helen (2017). "Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in ... Jerse, AE; Bash, MC; Russell, MW (20 March 2014). "Vaccines against gonorrhea: current status and future challenges". Vaccine. ... homology in their genetic sequences some cross-protection by meningococcal vaccines is plausible. ...
*  Lois Privor-Dumm
... she worked as Commercial Director for the Latin American countries to introduce pneumococcal and meningococcal vaccines. Later ... 2010). "Global use of Haemophilus influenzae type b conjugate vaccine". Vaccine. 28 (43): 7117-22. doi:10.1016/j.vaccine. ... The example of the Haemophilus influenzae type b vaccine". Vaccine. 29 (13): 2371-80. doi:10.1016/j.vaccine.2010.11.090. PMID ... Hib Vaccine Could Reduce Major Childhood Diseases Getting life-saving vaccines to those who need it most: the nuanced solution ...
*  Meningitis Vaccine Project
... and widespread use of conjugate meningococcal vaccines. The Project recently developed MenAfriVac, a low-cost conjugate A ... to manufacture the vaccine, the Project was able to develop a vaccine that would be affordable to developing African countries ... African meningitis belt 2009-10 West African meningitis outbreak Meningococcal vaccine Official website PATH project page. ... Unlike existing vaccines, MenAfriVac also provides immunity for a long period of time - 10 to 15 years - and is safe for use in ...
*  Advisory Committee on Immunization Practices
The proposed wording was as follows: "A serogroup B meningococcal (MenB) vaccine series may be administered to adolescents and ... On June 24, 2015, ACIP heard the arguments for recommending Pfizer and Novartis's serogroup B meningococcal vaccines for ... At meetings the ACIP may vote to include new vaccines into the VFC program or to modify existing vaccine schedules. These votes ... Category B is reserved for vaccines which, while proven adequate in some areas, are lacking evidence for others. These vaccines ...
*  MeNZB
Evidence based information on meningococcal disease and MeNZB vaccine. MeNZB information from vaccine manufacturer Chiron's ... "MeNZB vaccine and epidemic control: when do you stop vaccinating?". Vaccine. 26 (47): 5899-904. doi:10.1016/j.vaccine.2008.08. ... MeNZB was a vaccine against a specific strain of group B meningococcus, used to control an epidemic of meningococcal disease in ... Petousis-Harris, Helen (2017). "Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in ...
*  Splenectomy
... the patient should receive the pneumococcal conjugate vaccine (Prevnar), Hib vaccine, and the meningococcal vaccine; see ...
*  List of MeSH codes (D20)
... lyme disease vaccines MeSH D20.215.894.135.500 --- meningococcal vaccines MeSH D20.215.894.135.535 --- pertussis vaccine MeSH ... measles vaccine MeSH D20.215.894.899.404.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.488 --- mumps vaccine MeSH ... hepatitis a vaccines MeSH D20.215.894.899.955.400 --- hepatitis b vaccines MeSH D20.215.894.899.970 --- yellow fever vaccine ... rubella vaccine MeSH D20.215.894.899.779.500 --- measles-mumps-rubella vaccine MeSH D20.215.894.899.790 --- saids vaccines MeSH ...
*  Vaccination policy
HPV vaccine coverage increased well, and pneumococcal vaccine and meningococcal C vaccines faced positive public reception. ... "The French National Debate on Vaccine Safety". The Vaccine Reaction. National Vaccine Information Center. Missing or empty ,url ... Vaccines and Immunisation 2003. Based on the Third World Congress on Vaccines and Immunisation. 21 (7-8): 596-600. doi:10.1016/ ... This requirement stirred controversy when it was applied to the HPV vaccine in July 2008 because of the cost of the vaccine, ...
*  Asplenia
Children too young for the conjugate vaccine should receive meningococcal polysaccharide vaccine in the interim. Influenza ... in the UK may be given as a combined Hib/MenC vaccine). Meningococcal conjugate vaccine, especially if not received in ... Haemophilus influenzae type b vaccine, especially if not received in childhood. For adults who have not been previously ... ISBN 0-11-322528-8. - see pages 50-1 and table 7.1 "Meningococcal - Children and adults with asplenia or splenic dysfunction" ( ...
*  Bruce F. Scharschmidt
... the meningococcal C vaccine used to help curb deadly outbreaks in Canada and the UK, a tetravalent meningococcal vaccine ... "FLUAD™ Flu Vaccine With Adjuvant- Seasonal Influenza (Flu) - CDC". cdc.gov. Retrieved 20 March 2017. "MENJUGATE 10 micrograms ... and played a central role in the early development of several novel vaccines subsequently approved in the US and/or Europe, ... where he served as Corporate VP responsible for the clinical development of both therapeutics and vaccines until its ...
*  Public Readiness and Emergency Preparedness Act
... investigation for being connected to at least five cases of Guillain-Barré syndrome caused by its meningococcal vaccine. When ... Vaccine manufacturers lobbied for the legislation, which would effectively preempt state vaccine safety laws in the case of an ... can be used in the vaccine, even in states that have enacted such bans. Vaccines for the New Millennium Act ... and would supersede any state provision governing vaccines. PREPA applies to any drug, vaccine, or biological product that the ...
*  Charlotte Cleverley-Bisman
"Parents urged to take up vaccine". TVNZ. 8 July 2004. Official website Vaccine campaign beating meningococcal epidemic, 3 July ... Johnston, Martin (3 July 2006). "Vaccine campaign beating meningococcal epidemic". The New Zealand Herald. Auckland. Cameron, ... "Baby wins meningococcal fight" Archived 25 November 2007 at the Wayback Machine., Television New Zealand, 10 August 2004. ... In 2004, New Zealand was in the thirteenth year of an epidemic of meningococcal disease, a bacterial infection which can cause ...
*  Hazleton Area School District
... high school students are mandated to receive a dose of MCV meningococcal conjugate vaccine for 12th grade entry. Nurses also ...
*  JN-International Medical Corporation
Meningococcal meningitis diphtheria conjugate vaccine NmVac4-A/C/Y/W-135 - DT Meningococcal meningitis diphtheria conjugate ... Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135. United States ... vaccine for the prevention of Meningococcal meningitis serogroups A, C, Y and W-135 Diphtheria conjugate vaccine. Phase-1 and 2 ... The facility has a targeted production of 10 million doses of vaccine annually. cGMP vaccine facility. cGMP facility inside. ...